Psychopharmacological treatment of dermatological patients - When simply talking does not help;Psychopharmakologische behandlung dermatologischer patienten - Wenn reden allein nicht hilft

JDDG - Journal of the German Society of Dermatology

Volumn 5, Issue 12, 2007, Pages 1101-1106

  Harth, Wolfgang ^a   Seikowski, Kurt ^b   Gieler, Uwe ^c   Niemeier, Volker ^d   Hillert, Andreas ^e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL GIESSEN   (Germany)

^e Medical Psychosomatic Clinic Roseneck   (Germany)

Author keywords

Anxiety; Delusions of parasitosis; Depression; Dermatology; Psychopharmaceuticals

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; BUSPIRONE; CITALOPRAM; CLOMIPRAMINE; DIAZEPAM; DOXEPIN; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; LORAZEPAM; MIDAZOLAM MALEATE; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; OLANZAPINE; OXAZEPAM; PAROXETINE; PHOSPHODIESTERASE INHIBITOR; PIMOZIDE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE PLUS TRIFLUOPERAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ACCOMMODATION PARALYSIS; AGITATION; ANTICHOLINERGIC SYNDROME; ANXIETY DISORDER; AUTONOMIC NEUROPATHY; CONSTIPATION; DELUSION; DEPRESSION; DIARRHEA; DRIVING ABILITY; DRUG DEPENDENCE; DRUG DOSE INCREASE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EMOTIONAL DISORDER; ERECTILE DYSFUNCTION; EXTRAPYRAMIDAL SYMPTOM; HEADACHE; HEART ARRHYTHMIA; HUMAN; INSOMNIA; LIBIDO DISORDER; MENTAL CONCENTRATION; NAUSEA; NERVOUSNESS; OBSESSIVE COMPULSIVE DISORDER; PALLIATIVE THERAPY; PANIC; PATIENT COMPLIANCE; PSYCHOPHARMACOLOGY; PSYCHOSIS; RESPIRATION DEPRESSION; REVIEW; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SKIN MANIFESTATION; SLEEP DISORDER; SOMATIZATION; SOMATOFORM DISORDER; SUICIDE; TREATMENT INDICATION; TREATMENT PLANNING; WEIGHT GAIN; WITHDRAWAL SYNDROME; XEROSTOMIA;

ANXIETY DISORDERS; COMBINED MODALITY THERAPY; DELUSIONS; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PSYCHOPHYSIOLOGIC DISORDERS; PSYCHOTHERAPY; PSYCHOTIC DISORDERS; PSYCHOTROPIC DRUGS; SKIN DISEASES; SOMATOFORM DISORDERS;

EID: 36948998967     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2007.06398.x     Document Type: Review

References (41)

1. Harth W, Gieler U. Psychosomatische Dermatologie. Heidelberg : Springer Medizin Verlag, 2006.
2. Hoegl L, Hillert A, Fichter M. Psychopharmakologische Therapie und Hauterkrankungen. Psycho. 1996 22 : 513 516.
3. Benkert O, Hippius H. Kompendium der Psychiatrischen Pharmakotherapie. 6. Auflage, Springer Verlag, Berlin Heidelberg New York, 1996.
4. Dufresne RG, Phillips KA. Body Dysmorphic Disorder A guide for dermatologists and cosmetic surgeons. Am J Clin Dermatol. 2000 1 (4 235 243.
5. Lee E, Murase J, Koo J, Lee CS. Psychopharmacology in Dermatological Practice: A Review and Update. Dermatol Psychosom. 2003 4 : 131 140.
6. Koblenzer C.S. The Use of Psychotropic Drugs in Dermatology. Dermatol Psychosom. 2001 2 : 167 176.
7. Koo JY, Ng TC. Psychotropic and neurotropic agents in dermatology: unapproved uses, dosages, or indications. Clin Dermatol. 2002 20 (5 582 594.
8. Gupta MA, Gupta AK. The use of antidepressant drugs in dermatology. J Eur Acad Dermatol Venereol. 2001 15 (6 512 518.
9. Lee CS, Koo J. Psychopharmacologic therapies in dermatology: an update. Dermatol Clin. 2005 23 (4 735 744.
10. Navi D, Koo J. Safety update on commonly used psychotropic medications in dermatology. J Drugs Dermatol. 2006 5 (2 109 115.
11. Graff-Radford SB, Shaw LR, Naliboff BN. Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin J Pain. 2000 16 (3 188 192.
12. Kanazi GE, Johnson RW, Dworkin RH. Treatment of postherpetic neuralgia: an update. Drugs. 2000 59 (5 1113 1126.
13. Bernstein JE, Whitney DH, Soltani K. Inhibition of histamine-induced pruritus by topical tricyclic antidepressants. J Am Acad Dermatol. 1981 5 (5 582 585.
14. Vythilingum B, Stein DJ. Obsessivecompulsive disorders and dermatologic disease. Dermatol Clin. 2005 23 (4 675 680.
15. Lee E, Koo M. Psychotropic Medikations in Dermatology. In : Koo JMY, Lee CS, editors : Psychocutaneus medicine. New York, Basel : Marcel Dekker Inc., 2003 : 427 451.
16. Simeon D, Stein DJ, Gross S, Islam N, Schmeidler J, Hollander E. A doubleblind trial of fluoxetine in pathologic skin picking. J Clin Psychiatry. 1997 58 (8 341 347.
17. Phillips KA, McElroy SL, Dwight MM, Eisen JL, Rasmussen SA. Delusionality and response to openlabel fluvoxamine in body dysmorphic disorder. J Clin Psychiatry. 2001 62 (2 87 91.
18. Otley CC, Nguyen TH, Phillips PK. Anxiolysis with oral midazolam in pediatric patients undergoing dermatologic surgical procedures. J Am Acad Dermatol. 2001 45 (1 105 108.
19. Sass H, Wittchen HU, Zaudig M. Diagnostisches und Statistisches Manual Psychischer Störungen DSMIV. Berlin Toronto Seattle : Hogrefe Verlag für Psychologie, 2001.
20. Hamann K, Avnstorp C. Delusions of infestation treated by pimozide: a double- blind crossover clinical study. Acta Derm Venereol. 1982 62 (1 55 58.
21. Elmer KB, George RM, Peterson K. Therapeutic update: use of risperidone for the treatment of monosymptomatic hypochondriacal psychosis. J Am Acad Dermatol. 2000 43 (4 683 686.
22. Meehan WJ, Badreshia S, Mackley CL. Successful treatment of delusions of parasitosis with olanzapine. Arch Dermatol. 2006 142 (3 352 355.
23. Wenning MT, Davy LE, Catalano G, Catalano MC. Atypical antipsychotics in the treatment of delusional parasitosis. Ann Clin Psychiatry. 2003 15 (3- 4 233 239.
24. Blasco-Fontecilla H, Bragado Jimenez MD, Garcia Santos LM, Barjau Romero JM. Delusional disorder with delusions of parasitosis and jealousy after stroke: treatment with quetiapine and sertraline. J Clin Psychopharmacol. 2005 25 (6 615 617.
25. Niemeier V, Kupfer J, Gieler U. Observations during an itch- inducing lecture. Dermatol Psychosom. 2000 1 : 15 18.
26. Zenker S, Schuh T, Degitz K. Behandlung von Pruritus als Symptom von Hauterkrankungen mit dem Serotonin- Rezeptorantagonist Ondansetron. JDDG. 2003 1 : 705 710.
27. Niemeier V, Kupfer J, Harth W, Brosig B, Schill WB, Gieler U. Sind Patienten mit Glossodynie psychisch unauffällig? Eine psychodiagnostisch schwer fassbare Erkrankung. Psychother Psych Med Psychologie. 2002 52 : 425 432.
28. Sasaki K, Smith CP, Chuang YC, Lee JY, Kim JC, Chancellor MB. Oral gabapentin (neurontin) treatment of refractory genitourinary tract pain. Tech Urol. 2001 7 (1 47 49.
29. Krege S, Ludwig M, Kloke M, Rubben H. Chronic pain syndrome in uorology. Urologe. 2003 42 (5 669 674.
30. Kivanc-Altunay I, Savas C, Gokdemir G, Koslu A, Ayaydin EB. The presence of trichodynia in patients with telogen effluvium and androgenetic alopecia. Int J Dermatol. 2003 42 (9 691 693.
31. Aw DC, Thong JY, Chan HL. Delusional parasitosis: case series of 8 patients and review of the literature. Ann Acad Med Singapore. 2004 33 (1 89 94.
32. Mutschler E, Geisslinger G, Kroemer H, Schäfer-Korting. Arzneimittelwirkungen. 8. Auflage, Stuttgart : Wissenschaftliche Verlags GmbH, 2001.
33. Phillips KA. Psychosis in body dysmorphic disorder. Psychiatr Res. 2004 38 (1 63 72.
34. Harth W, Wendler M, Linse R. Lifestyle drugs and body dysmorphic disorder: Overview on a new phenomenon in dermatology. Dermatology and Psychosomatics. 2002 3 : 72 76.
35. Hollander E, Allen A, Kwon J, Aronowitz B, Schmeidler J, Wong C. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry. 1999 56 (11 1033 1039.
36. Phillips KA, Albertini RS, Rasmussen SA. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry. 2002 59 : 381 388.
37. Phillips KA, Najjar F. An open-label study of citalopram in body dysmorphic disorder. J Clin Psychiatry. 2003 64 (6 715 720.
38. Phillips KA. An open-label study of escitalopram in body dysmorphic disorder. Int Clin Psychopharmacol. 2006 21 (3 177 179.
39. Harth W, Mayer K, Linse R. Borderline Syndrome in Psychosomatic Dermatology. J Eur Acad Dermatol Venereol. 2004 18 (4 503 507.
40. Nickel MK, Muehlbacher M, Nickel C, Kettler C, Pedrosa Gil F, Bachler E, Buschmann W, Rother N, Fartacek R, Egger C, Anvar J, Rother WK, Loew TH, Kaplan P. Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2006 163 (5 833 838.
41. Davidson JR. Pharmacologic treatment of acute and chronic stress following trauma: 2006. J Clin Psychiatry. 2006 67 Suppl. 2 : 34 39.